Bimatoprost / working resource
Clinical conversation planner
Bring specific questions and a source record to a qualified clinician.
Start with the product-specific question
What the label says it is for
Bimatoprost for short or sparse eyelashes, with the evidence and its limits in plain view. What should I know about what the label says bimatoprost is for?
Open the Bimatoprost library ↗In a 2012 randomized trial, subjects were randomized over 5 months to once-daily bimatoprost 0.03% (n = 137) or vehicle (n = 141). A higher percentage of subjects treated with bimatoprost 0.03% (78.1%) than vehicle (18.4%) demonstrated at least a 1-grade increase in global eyelash assessment score at week 16 (P < .0001). The abstract lists the short-term duration of the trial and that black subjects were not enrolled secondary to technical requirements of digital image analysis as limitations.
Read the original record ↗
Choose the questions that need an answer.
Use the Bimatoprost research to prepare a conversation, then let the clinician assess your individual situation. This worksheet does not determine eligibility or treatment.
Your conversation agenda
Select questions above to create your agenda here.
Share personal health details only through your care provider's appropriate private channel. This page does not send or save your notes.
These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.